GLP-1 Drugs

Preliminary study finds that testosterone levels increase or stabilize in people taking GLP-1 medications

A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and too fast to lose?

While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors

Ozempic and just getting older take off muscle. New therapies could retain it

With millions of people now using GLP-1 drugs such as Wegovy and Zepbound, scientists are racing to find ways to help people retain their weight loss after they stop taking the medication

A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight inflammation

The weight you lose and the nausea you experience from GLP-1 drugs may be linked to common gene variants, but they can’t fully explain why some people lose more weight than others

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks

“Imitation” drugs, unexpected benefits, serious pitfalls—here’s what comes next as GLP-1 medications continue to rise in popularity

Three types of diabetes medication are improving the outlook for patients with kidney disease

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths